Another recent study demonstrated anticancer effects of the BET bromodomain inhibitor OTX015 and the proteasome inhibitor carfilzomib by TERT down-regulation in TERT-rearranged neuroblastoma cell lines [20]. The gene discussed is DNER; the disease is neuroblastoma.